Biomea Fusion Stock (NASDAQ: BMEA) stock price, news, charts, stock research, profile.
Open | $5.41 |
Close | $5.60 |
Volume / Avg. | 551.78K / 1.33M |
Day Range | 5.31 - 5.65 |
52 Wk Range | 3.61 - 23.92 |
Market Cap | $195.18M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 35.71% |
Days to Cover | 3.88 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Biomea Fusion (NASDAQ:BMEA) through any online brokerage.
Other companies in Biomea Fusion’s space includes: Molecular Partners (NASDAQ:MOLN), Outlook Therapeutics (NASDAQ:OTLK), Renovaro (NASDAQ:RENB), Skye Bioscience (NASDAQ:SKYE) and Adverum Biotechnologies (NASDAQ:ADVM).
There is no analysis for Biomea Fusion.
Biomea Fusion has a consensus price target of $24.85.
The stock price for Biomea Fusion (NASDAQ: BMEA) is $5.43 last updated Today at July 16, 2024 at 5:08 PM EDT.
There are no upcoming dividends for Biomea Fusion.
Biomea Fusion’s Q2 earnings are confirmed for Monday, July 29, 2024.
There is no upcoming split for Biomea Fusion.
Biomea Fusion is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.